Search

BIOTECH PHARMACEUTICAL HOLDING MAY BECOME BANKRUPT. THE LAWSUITS CONTINUE

... firm has not signed new contracts since May 2022. One of the risk factors that market participants do not want to deal with Biotech may be a case of bribery. In addition to the spouses Boris and Evgenia Shpigel, the former head of the region Ivan Belozertsev ... ... of payments that the arbitration awarded to the holding for the previous 4 years. Since the beginning of 2022, the number of lawsuits against companies has exceeded several dozen. Some of them, in the amount of 900 million rubles, have already found support ...

Sorted by relevance | Sort by date